About Toxys
Toxys is a company based in Leiden (Netherlands) founded in 2014. Toxys has raised $2.26 million across 2 funding rounds from investors including Rabobank, InnovationQuarter and KIKK Capital. Toxys offers products and services including ToxTracker, ReproTracker, and ToxProfiler. Toxys operates in a competitive market with competitors including Altis Biosystems, ATANIS Biotech, Inovotion, BioTalentum and Foresee Biosystems, among others.
- Headquarter Leiden, Netherlands
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.26 M (USD)
in 2 rounds
-
Latest Funding Round
$2.26 M (USD), Series A
Mar 16, 2020
-
Investors
Rabobank
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Toxys
Toxys offers a comprehensive portfolio of products and services, including ToxTracker, ReproTracker, and ToxProfiler.
Discriminates DNA damage and oxidative stress mechanisms for toxicity assessment.
hiPSC-based test for early embryonic development and teratogen identification.
Mechanistic tool for understanding non-genotoxic carcinogen pathways.
People of Toxys
Unlock access to complete
Unlock access to complete
Funding Insights of Toxys
Toxys has successfully raised a total of $2.26M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $2.26 million completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Toxys
Toxys has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Rabobank, InnovationQuarter and KIKK Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
KIKK Capital is engaged in investing in Dutch start-ups.
|
Locked | Locked | Locked | |
|
Sector-agnostic VC firm investing primarily in the Netherlands
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Toxys
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Toxys
Investment portfolio details for Toxys
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Toxys
Detailed financials for Toxys
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Toxys Comparisons
Peer comparison for Toxys
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Toxys
Toxys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Altis Biosystems, ATANIS Biotech, Inovotion, BioTalentum and Foresee Biosystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of invitro platform for drug testing
|
|
| Locked | Locked | Locked |
Developer of a cell-based assay for the diagnosis of allergies
|
|
| Locked | Locked | Locked |
Provider of in vivo oncology efficacy and toxicity assays for drug discovery and development
|
|
| Locked | Locked | Locked |
Human stem-cell technologies for drug testing and toxicology are provided.
|
|
| Locked | Locked | Locked |
Developer of in vitro assays for detection of potential toxicity in drug discovery
|
Detailed competitors of Toxys
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Toxys
Complete news archive for Toxys
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Toxys
Toxys was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Toxys is headquartered in Leiden, Netherlands. It is registered at Leiden, South Holland, Netherlands.
Toxys is a funded company, having raised a total of $2.26M across 2 funding rounds to date.
Toxys was founded in 2014 in Leiden, Netherlands, and operates in the biotechnology sector focused on safety testing. In vitro genotoxicity assessments are conducted through the ToxTracker method, which evaluates carcinogenicity and genotoxicity in mouse embryonic stem cells. Custom testing services are also available, along with the ToxPlot software for data analysis. Operations center on chemical and drug compound evaluations for regulatory compliance.
Toxys's top competitors include Altis Biosystems, ABL Diagnostics and ATANIS Biotech.
Toxys offers ToxTracker, ReproTracker, and ToxProfiler.
Toxys has 4 investors. Key investors include Rabobank, InnovationQuarter, KIKK Capital, and Zeeuws Investerings Fonds.